Type 2 & other diabetes

Development and evaluation of a machine learning prediction model for short-term mortality in patients with diabetes or hyperglycemia at emergency department admission

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

A machine learning model based on routinely collected data in the ED accurately predicted 30-day mortality with high specificity and sensitivity. This approach shows promise in identifying high-risk patients requiring close monitoring and timely interventions.

Study context

Population
Patients aged > 18 years with diabetes or hyperglycemia (glucose > 11 mmol/L) at all nine emergency department (EDs) in Region Skåne, 2017 to 2018
Participants
34,280 patients74,611 ED visits
Exposure
Men 40-69 vs Men ≥ 70 vs Women 40-69 vs Women ≥ 70
Outcome
30-day mortality prediction
Follow-up
30 days
Methodological detailsprognostic model development and validation, machine learning, stochastic gradient boosting, trained in some hospitals, tested in others
  • Prognostic model development and validation
  • Machine learning
  • Stochastic gradient boosting
  • Trained in some hospitals, tested in others

Main finding

As reported in the abstract

Model performance for 30-day mortality across the four groups
Sensitivity
86-97%
Specificity
86-94%
Accuracy
86% to 94%
AUC
0.84 to 0.93
Cohen's kappa
0.34 to 0.45
PPV
23% to 37%

Observational data: associations, not effects.

Further findings

Key predictors (normalized relative influence (NRI) scores)

Laboratory values (pH, base excess, pCO2, standard bicarbonate, oxygen saturation, lactate, CRP, leukocytes), age, triage category and time to doctor consultation

Original publication

Development and evaluation of a machine learning prediction model for short-term mortality in patients with diabetes or hyperglycemia at emergency department admission. Cardiovasc Diabetol. Published 3 October 2025. doi:10.1186/s12933-025-02954-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.